For example, in June 2025, Connecticut Attorney General released a statement warning businesses of allegedly or potentially unfair and deceptive conduct related to compounding of GLP-1 medications
If pancreatitis is suspected, stop taking Ozempic and seek urgent medical assessment [1] Signs of gallbladder problems: persistent pain in the upper right abdomen, fever, yellowing of the skin or eyes (jaundice) Any changes in vision, which could indicate worsening of diabetic retinopathy Severe gastrointestinal symptoms leading to dehydration (excessive thirst, reduced urination, dizziness) If you have a pre-existing immune condition (such as an autoimmune disease or immunodeficiency), or if you are taking immunosuppressive medications, inform your healthcare provider before starting Ozempic
Compounders can still make copycat weight loss drugs, but are losing their market advantage of widespread telehealth distribution and favorable pricing as brand-name GLP-1 prices decline , including for new pills
They stated that they will give compounders a 60 to 90-day grace period to discontinue making and marketing their versions of semaglutide in order to avoid unnecessary disruption to patient treatment and to help facilitate an orderly transition